PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced Ovarian Cancers

AstraZeneca's Lynparza (olaparib) + Bevacizumab Receive the US FDA's Priority Review for 1L Treatment of Advanced Ovarian Cancers

AstraZeneca's Lynparza (olaparib) + Bevacizumab Receive the US FDA's Priority Review for 1L Treatment of Advanced Ovarian Cancers

January 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us